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TEMPORAL ASPECTS OF DNA RE-
PAIR PROCESSES AFTER DRUGS
AND RADIATION. B. W. Fox, Paterson
Laboratories, Christie Hospital and Holt
Radium Institute, M4nchester.
Before considering the ultimate effect of
drug and radiation in combination on
biological end points such as cell cycle phase
parameter changes, mutation frequency and
eventually survival, it is desirable to know
what sequence of changes may be expected
following the drug or radiation treatment
alone. The timing of events within the cell
attempting to overcome damage to its DNA
will depend on (a) the nature and multiplicity
of the lesions produced on the DNA, (b) the
genetic competence of the cell to undertake
the different types of repair required by such
lesions, (c) the conditions under which the cell
is growing which may favour or hinder
different repair mechanisms and (d) the
efficiency ofeach repair event in restoring the
full competence of the original DNA in its
transcriptional and replicative roles. Diffi-
culties experienced during these events may
determine the subsequent fate of the cell.
These difficulties result from a subtle inter-
play of dose-time relationships of the
characteristic biochemical disturbances
exerted by each agent. An attempt has been
made to understand the interplay of some of
these events using alkylating agents such as
methyl methane sulphonate and methyl-
nitro-nitrosoguanidine and comparing them
with both x-rays and ionizing radiation.
The present status ofsuch studies designed to
rationalize combination treatment could not
be considered to do more than influence to a
small extent an otherwise empirical approach
to combination treatment.
EFFECTS OF DAUNOMYCIN, BLEO-
MYCIN, CYTOSINE ARABINOSIDE,
ACRONYCINE AND IONIZING
RADIATION ON THE CELL CYCLE
IN VITRO AND IN VIVO. W. A. LINDEN,
S. B. REDDY and F. ZYWIETZ, Institut fur
Biophysik und Strahlenbiologie der Univer-
sitait Hamburg.
Four chemotherapeutic agents without, or
in combination with, 200 kV x-rays were
examined for their influence on cell cycle
progression and viability of mouse L-cells.
The action of daunomycin and ionizing
radiation was also tested on the Walker
carcinoma in vivo. The cell kinetics after
different treatments were studied using the
technique of pulse cytophotometry. By this
method, DNA distribution patterns (DNA
histograms) of the cells were obtained. The
mathematical analysis of the DNA histo-
grams yields the fractions ofcells in G1, S and
G2 or M. Cytosine arabinoside predomi-
nantly blocked the cells in S phase while
daunomycin, bleomycin and acronycine ac-
cumulated the cells in (G2 + M)-phase.
These results vary in combination with
irradiation.
EFFECTS OF INTERACTIONS OF
CELL CYCLE-SPECIFIC CYTOTOXIC
DRUGS AND X-RADIATION ON
SURVIVAL OF CELL REPRODUCTIVE
CAPACITY. R. J. BERRY, MRC Radio-
biology Unit, Harwell.
Cells of murine leukaemia P-388 in vivo
and HeLa cells in vitro have been used for
several years to study interactions between
effects of cytotoxic chemotherapeutic agents,
including halopyrimidines and folic acid
antagonists, and subsequent survival of cell
reproductive capacity after x-irradiation.
Using these latter classes of drugs as specific
examples, combination of information on
drug radiation interactions with even our
limitedknowledge ofcellproliferationkinetics
in tumours and dose limiting normal tissues
allows some predictions to be made about
effects of the sequential and concomitant use
of cytotoxic drugs with conventional and
unorthodox dose fractionation in radio-
therapy.
EFFECTIVENESS OF COMBINED
TREATMENTS OF VARIOUS TYPES
OF TRANSPLANTABLE RAT
TUMOUR WITH IONIZING RADIA-
TION AND DRUGS. G. W. BARENDSEN,
A. F. HERMENS and H. C. JANSE, Radio-
biological Institute TNO, Rijswijk.
Many tumours in animals and man
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non-proliferating (Q) cells, which may differ
in their sensitivity to drugs or ionizing
radiation. Experimental data on changes in
cell proliferation characteristics of a trans-
plantable R-1 rat rhabdomyosarcoma have
shown that the fraction of P cells may
increase and the cell cycle time may decrease
after irradiation. This has led to experiments
on the effectiveness of a cell cycle-specific
drug given at various time jntervals after
irradiation.
Growth delay of the R-1 rhabdomyo-
sarcoma was measured after doses of2000 rad
or 1000 rad of x-rays, followed at intervals of
up to 12 days by the administration of
vinblastine at a dose level of 1-5 mg/kg of
body weight. This dose of vinblastine alone
induced a growth delay of 2.5 days, while
1000 rad and 2000 rad of x-rays induced
growth delays of 7 and 15 days respectively.
Vinblastine given 8 h before irradiation gave
approximately the same effect as irradiation
only, but vinblastine given 48-192 h after
irradiation caused a very significant excess
delayofabout 8 days over that expected from
a directly additive action. This can be
ascribed to recruitment of Q cells into the
compartment ofP cells. Asimilarsynergistic
effect was observed for a rat osteosarcoma but
not for a rat skin carcinoma and a rat bladder
carcinoma.
Work supported under contract NO1-
CM-53763 by the National Cancer Institute
USA.
IN VIVO INVESTIGATIONS ABOUT
THE EFFECTS OF RADIATION
AND/OR DRUGS IN NORMAL
TISSUE AND IN SARCOMA-180. W.
PORSCHEN and L. E. FEINENDEGEN, Labora-
tory of Neutron Biology and Cellular Tumor
Kinetic, Institut fur Medizin, KFA, Julich.
An external assay has been developed and
modified in this laboratory that permits the
evaluation of the effects of radiation and/or
drugs in the living mouse. Cells are labelled
in vivo with iododeoxyuridine (1251UdR).
IUdR is an analogue of thymidine; both
precursors are specifically and rapidly incor-
porated into DNA of S cells at the time the
precursors are made available. Reutilization
of IUdR is minimal; therefore labelled
IUdR is the tracer of choice for turnover
studies. The soft y-rays from 1251 are easily
measured externally, either with the whole
body counter or with a tumour measuring
device specifically developed for assaying
solid tumours.
This paper reports on the effect of radia-
tion and/or drugs on the rate ofincorporation
of '25JUdR into whole body DNA and
tumour DNA in the living mouse. In
addition, the effect of actinomycin D on the
rate ofturnover oflabelled tumour cells in the
living mouse was assayed. Prolonged obser-
vations in the living organism with this
technique do not disturb the physiological
equilibrium, be it in normal or in tumour
bearing animals. In this study, sarcoma-180
was used as a solitary tumour growing in the
hind leg ofNMRI mice; 10-12 mice were used
per experimental point.
The incorporation of 125IUdR into whole
body DNA on one hand and tumour DNA on
the other hand was measured in the living
mice at various times after acute exposure to
y-radiation, neutron radiation or after a
single administration offluorouracil, hydroxy-
urea and actinomycin D. Each of these
treatments caused a specific effect ofdifferent
duration and the maximum effect in the
whole body surpassed that observed for the
tumour. On the other hand, a single
administration of a platinum complex
compound (cis-dichloro-diammine-platinum)
caused not only prolonged effects in the whole
body and tumour but the effects to the
tumour surpassed that of the whole body:
combined effects of actinomycin D and
radiotherapy on sarcoma-180 were different
from those seen in the whole body. In both
instances, the additional effect ofactinomycin
D resembled the maximal effect of either
treatment alone. It was found that actino-
mycin D enhanced the radiation effect on
tumour growth when it was given 3-4 h
either before or after irradiation. Actino-
mycin D treatment or combined therapy
indicated that actinomycin D alone had little
effect on cell loss rate from labelled tumours.
Combined therapy did not significantly alter
the increased rate of cell loss observed for
radiotherapy alone, yet combined therapy
appeared to cause the enhanced cell loss rate
to be prolonged in comparison with radio-
therapy alone.
COMBINED EFFECT OF 5-FU AND
60Co ON INTESTINE, BONE
MARROW AND ON TRANSPLANTED
TUMOUR IN MICE. A POSSIBLE